Publications by authors named "Michael Butzner"

Claim this Profile
L
Longitudinal analyses of healthcare resource utilization and costs among patients with obstructive hypertrophic cardiomyopathy.
Nosheen Reza, Michael Butzner, Kirti Batra, Qiana Amos, Ami Buikema

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Care Resource Use and Economic Burden in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy and Atrial Fibrillation.
John C Stendahl, Sounok Sen, Michael Butzner, Eros Papademetriou, Ravi Potluri

J Am Heart Assoc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Hospitalizations Burden Following Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.
Ahmed Altibi, Miriam Elman, Hailey Volk, Mohammad Alqabani, Michael Butzner

J Am Heart Assoc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of sex on economic burden in patients with symptomatic obstructive hypertrophic cardiomyopathy: results from medical and pharmacy claims data.
Michael Butzner, Sanika Amonkar, Meiling Chen, Eros Papademetriou, Ravi Potluri

Front Cardiovasc Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicoeconomic burden among heart failure patients with severely reduced ejection fraction after hospital admission: HF-RESTORE.
Heidi T May, Jeffrey L Anderson, Michael Butzner, Punag H Divanji, Joseph B Muhlestein

Eur Heart J Qual Care Clin Outcomes· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Healthcare Resource Use and Cost by Pharmacotherapy Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of Claims Data.
Michael Butzner, Eros Papademetriou, Ravi Potluri, Xing Liu, Sanatan Shreay

Am J Cardiovasc Drugs· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.
Charles F Sherrod, Sara Saberi, Michael E Nassif, Brian L Claggett, Caroline J Coats, Michael Butzner

J Am Coll Cardiol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative interview study of patient-reported symptoms, impacts and treatment goals of patients with obstructive hypertrophic cardiomyopathy.
Supriya Shore, Claire Ervin, Katherine Kosa, Sheri Fehnel, Lisa Salberg, Michael Butzner

BMJ Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evidence review and gap analysis for obstructive hypertrophic cardiomyopathy.
Michael Butzner, Elise Aronitz, Heather Cameron, Krista Tantakoun, Sanatan Shreay

BMC Cardiovasc Disord· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of peak oxygen uptake in obstructive hypertrophic cardiomyopathy: a literature review to inform economic model development.
Michael Butzner, Csilla Kinyik-Merena, Magda Aguiar, Niall Davison, Sanatan Shreay

J Med Econ· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving or placebo in FORTITUDE-ALS.
Paulos Gebrehiwet, Lisa Meng, Stacy A Rudnicki, Phil Sarocco, Jenny Wei, Michael Butzner

J Med Econ· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Health Literacy on Medication Adherence Among Black Medicaid Beneficiaries with Hypertension in Delaware: A Cross-Sectional Study.
Michael Butzner, Christiana Oyekanmi, Mary Joan McDuffie, Erin Nescott, Asli McCullers

Popul Health Manag· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs and Healthcare Resource Utilization for Obstructive Hypertrophic Cardiomyopathy With Septal Reduction Therapy.
Michael Butzner, Martin S Maron, Phil Sarocco, Chia-Chen Teng, Eric Stanek

J Invasive Cardiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Patients With Obstructive Hypertrophic Cardiomyopathy in Real-World Community-Based Cardiovascular Practices.
Michael Butzner, Phil Sarocco, Martin S Maron, Ethan Rowin, Chia-Chen Teng

Am J Cardiol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Healthcare Resource Utilization among Patients with Obstructive Hypertrophic Cardiomyopathy Treated in a Range of Settings in the United States.
Michael Butzner, Ethan Rowin, Amin Yakubu, Josiah Seale, Laura A Robertson

J Clin Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in clinical outcomes for obstructive hypertrophic cardiomyopathy in the USA: a retrospective observational study of administrative claims data.
Michael Butzner, Douglas Leslie, Yendelela Cuffee, Christopher S Hollenbeak, Christopher Sciamanna

BMJ Open· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse drug effects across patients with heart failure: a systematic review.
Michael Butzner, Ralph J Riello, Phil Sarocco, Nihar Desai

Am J Manag Care· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era.
Michael Butzner, Douglas L Leslie, Yendelela Cuffee, Christopher S Hollenbeak, Christopher Sciamanna

Front Cardiovasc Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and cost of obstructive hypertrophic cardiomyopathy in a US population.
Michael Butzner, Martin Maron, Phil Sarocco, Chia-Chen Teng, Eric Stanek

Am Heart J Plus· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Diagnosis of Hypertrophic Cardiomyopathy Over Time in the United States (A Population-Based Claims Analysis).
Michael Butzner, Martin Maron, Phil Sarocco, Ethan Rowin, Chia-Chen Teng

Am J Cardiol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining medication adherence and preferences for a lifestyle intervention among Black and Latinx adults with hypertension: a feasibility study.
Emily C Dougherty, Natasha Burse, Michael Butzner, Hongke Wu, Heather L Stuckey

Pilot Feasibility Stud· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telehealth Interventions and Outcomes Across Rural Communities in the United States: Narrative Review.
Michael Butzner, Yendelela Cuffee

J Med Internet Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world heart rate norms in the Health eHeart study.
Robert Avram, Geoffrey H Tison, Kirstin Aschbacher, Peter Kuhar, Eric Vittinghoff, Michael Butzner

NPJ Digit Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis